Zhe-ming Gu

2.0k total citations
52 papers, 1.6k citations indexed

About

Zhe-ming Gu is a scholar working on Molecular Biology, Biochemistry and Horticulture. According to data from OpenAlex, Zhe-ming Gu has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 29 papers in Biochemistry and 26 papers in Horticulture. Recurrent topics in Zhe-ming Gu's work include Traditional and Medicinal Uses of Annonaceae (29 papers), Cocoa and Sweet Potato Agronomy (26 papers) and Plant and Fungal Species Descriptions (12 papers). Zhe-ming Gu is often cited by papers focused on Traditional and Medicinal Uses of Annonaceae (29 papers), Cocoa and Sweet Potato Agronomy (26 papers) and Plant and Fungal Species Descriptions (12 papers). Zhe-ming Gu collaborates with scholars based in United States, China and South Korea. Zhe-ming Gu's co-authors include Jerry L. McLaughlin, Xin-ping Fang, Lu Zeng, Matthew J. Rieser, Guoen Shi, Lu Zeng, Kan He, Qing Ye, Geng‐Xian Zhao and Karl V. Wood and has published in prestigious journals such as The Journal of Organic Chemistry, Tetrahedron and Phytochemistry.

In The Last Decade

Zhe-ming Gu

49 papers receiving 1.5k citations

Peers

Zhe-ming Gu

BIOCH

HORTI

PHARM

Pan Li China

Chi‐Liang Chern Taiwan

Wen‐Yu Zhao China

Jin-Bin Wu Taiwan

Benjamin B. Davis United States

Mitchell Green United States

Yunliang Zheng China

Yusuf Temel Türkiye

Yuguang Lin Netherlands

Ronald E. Tynes United States

Pan Li China

Zhe-ming Gu

79 ×0.1

BIOCH

553 ×0.6

12 ×0.0

HORTI

153 ×0.6

173 ×0.7

PHARM

Citations per year, relative to Zhe-ming Gu Zhe-ming Gu (= 1×) peers Pan Li

Countries citing papers authored by Zhe-ming Gu

Since Specialization

Citations

This map shows the geographic impact of Zhe-ming Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe-ming Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe-ming Gu more than expected).

Fields of papers citing papers by Zhe-ming Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe-ming Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe-ming Gu. The network helps show where Zhe-ming Gu may publish in the future.

Co-authorship network of co-authors of Zhe-ming Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe-ming Gu. A scholar is included among the top collaborators of Zhe-ming Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe-ming Gu. Zhe-ming Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bian, Yicong, Sheng Ma, Hongting Li, et al.. (2024). Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study. Expert Opinion on Investigational Drugs. 33(1). 63–72.

Ma, Sheng, Yingying Yu, Caixia Sun, et al.. (2024). Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects. Drugs in R&D. 24(3). 465–476.

Li, Lin, Yixiang Wang, Qi Yu, et al.. (2023). In vitro and in vivo pharmacokinetics, disposition, and drug-drug interaction potential of tinengotinib (TT-00420), a promising investigational drug for treatment of cholangiocarcinoma and other solid tumors. European Journal of Pharmaceutical Sciences. 192. 106658–106658. 2 indexed citations

Bian, Yicong, Hua Zhang, Dong Tang, et al.. (2021). The metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [¹⁴C] cetagliptin in healthy volunteers. Xenobiotica. 52(1). 38–45. 4 indexed citations

Chen, Tao, Jin Qiu, Kai Guo, et al.. (2017). Pharmacokinetics, Metabolism and Disposition of [14C]XQ-1H After Intravenous Administration to Male Rats. Drug Metabolism Letters. 10(4). 228–239. 3 indexed citations

Zhao, Sylvia, Lingling Zhang, Xiaoyun Wu, et al.. (2014). 4β-Hydroxycholesterol as an Endogenous Biomarker of CYP3A Activity in Cynomolgus Monkeys. Drug Metabolism and Disposition. 42(5). 839–843. 9 indexed citations

Hoffmann, Matthew, Gondi Kumar, Peter Schäfer, et al.. (2011). Disposition, metabolism and mass balance of [¹⁴C]apremilast following oral administration. Xenobiotica. 41(12). 1063–1075. 41 indexed citations

Feng, Hao, Weiwei Liu, Rong Hu, et al.. (2009). Biotransformation of aesculin by human gut bacteria and identification of its metabolites in rat urine. World Journal of Gastroenterology. 15(12). 1518–1518. 17 indexed citations

Zhang, Donglu, Kan He, Nirmala Raghavan, et al.. (2009). Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans. Drug Metabolism and Disposition. 37(8). 1738–1748. 89 indexed citations

10.

Gu, Zhe-ming, Ruediger Nave, Hao Feng, et al.. (2007). Comparative In Vitro Metabolism of 14C-Ciclesonide in Hepatocytes From the Mouse, Rat, Rabbit, Dog, and Human. American Journal of Therapeutics. 14(3). 280–290. 6 indexed citations

11.

Gu, Zhe-ming, et al.. (1999). Quantitative evaluation of Annonaceous acetogenins in monthly samples of paw paw (Asimina triloba) twigs by liquid chromatography/electrospray ionization/tandem mass spectrometry. Phytochemical Analysis. 10(1). 32–38. 19 indexed citations

12.

Alali, Feras Q., et al.. (1998). Mono-THF ring annonaceous acetogenins from Annona squamosa. Phytochemistry. 47(5). 803–809. 22 indexed citations

13.

Gu, Zhe-ming, et al.. (1997). Isolation of new bioactive annonaceous acetogenins from Rollinia mucosa guided by liquid chromatography/mass spectrometry. Bioorganic & Medicinal Chemistry. 5(10). 1911–1916. 23 indexed citations

14.

Gu, Zhe-ming, et al.. (1997). Screening for Annonaceous Acetogenins in Bioactive Plant Extracts by Liquid Chromatography/Mass Spectrometry. Journal of Natural Products. 60(3). 242–248. 31 indexed citations

15.

Zeng, Lu, Qing Ye, Nicholas H. Oberlies, et al.. (1996). Recent advances in annonaceous acetogenins. Natural Product Reports. 13(4). 275–275. 322 indexed citations

16.

Shi, Guoen, Zhe-ming Gu, Kan He, et al.. (1996). Applying Mosher's method to acetogenins bearing vicinal diols. The absolute configurations of muricatetrocin C and rollidecins A and B, new bioactive acetogenins from Rollinia mucosa. Bioorganic & Medicinal Chemistry. 4(8). 1281–1286. 28 indexed citations

17.

Namba, Tsuneo, et al.. (1995). Pharmacognostical Study on the Chinese"Qiang-huo(羌活)"On the Anatomical Characteristics of the Underground Parts of Notopterygium incisum and N.forbesii. 49(4). 409–417. 2 indexed citations

18.

Gu, Zhe-ming, et al.. (1994). 10‐, 12‐, and 29‐Hydroxybullatacinones: New cytotoxic annonaceous acetogenins from nnona bullata rich (annonaceae). Natural Toxins. 2(2). 49–55. 10 indexed citations

19.

Gu, Zhe-ming, Xin-ping Fang, Laura R. Miesbauer, David L. Smith, & Jerry L. McLaughlin. (1993). 30-, 31-, and 32-Hydroxybullatacinones: Bioactive Terminally Hydroxylated Annonaceous Acetogenins from Annona bullata. Journal of Natural Products. 56(6). 870–876. 16 indexed citations

20.

Yang, Xiu‐Wei, Zhe-ming Gu, Ben-Xiang Wang, Masao Hattori, & Tsuneo Namba. (1991). Comparison of Anti-Lipid Peroxidative Effects of the Underground Parts ofNotopterygium incisumandN. forbesiiin Mice. Planta Medica. 57(5). 399–402. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact